Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical

Globally, the result was a drastic HIV-1 R5, but not X4, overproduction in EBI2-transduced cells.

Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the

GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery committed to leveraging his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

data analyst and the founder of Pharmechanics LLC , a consultancy and data analysis company supporting pharmaceutical Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences

He consults with numerous pharmaceutical, biotech, life science and academic organizations in understanding He worked as a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences

Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Pharmaceutical Industry Experiences and GPCR History Arthur shared his experiences in the pharmaceutical

I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical

Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical

Gilchrist is also an associate professor at the Department of Pharmaceutical Sciences.

Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development

Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development

By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb

These investigations have enabled him to foster strong collaborations with the pharmaceutical industry

Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused

He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility

He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility

University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical

Angers established his independent research program in the Department of Pharmaceutical Sciences at the

In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist

and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute of Pharmaceutical

of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical

explored the capacity of bioactive compounds derived from Gnetum gnemon (GG) for the development of of pharmaceuticals

of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical